|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Restricted cash | |||||||||
| Trade accounts receivable and other (including 272 and 322 from related parties at December 31, 2025 and 2024, respectively) | |||||||||
| Inventories | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Assets held for sale | |||||||||
| Total current assets | |||||||||
| Non-current assets: | |||||||||
| Goodwill and intangible assets | |||||||||
| Property, plant and equipment and biological assets | |||||||||
| Investments in associates and joint ventures | |||||||||
| Other investments | |||||||||
| Deferred tax assets | |||||||||
| Other assets | |||||||||
| Total non-current assets | |||||||||
| Total assets | |||||||||
| LIABILITIES AND EQUITY | |||||||||
| Current liabilities: | |||||||||
| Short-term debt and current portion of long-term debt | |||||||||
| Trade accounts payable and other (including 352 and 291 to related parties at December 31, 2025 and 2024, respectively) | |||||||||
| Short-term provisions | |||||||||
| Accrued expenses and other liabilities | |||||||||
| Income tax liabilities | |||||||||
| Liabilities held for sale | |||||||||
| Total current liabilities | |||||||||
| Non-current liabilities: | |||||||||
| Long-term debt, net of current portion | |||||||||
| Deferred tax liabilities | |||||||||
| Deferred employee benefits | |||||||||
| Long-term provisions | |||||||||
| Other long-term obligations | |||||||||
| Total non-current liabilities | |||||||||
| Total liabilities | |||||||||
| Equity: | |||||||||
| Common shares (no par value, 1,033,608,827 and 1,111,418,599 shares authorized, 775,000,000 and 852,809,772 shares issued, and 761,125,819 and 768,546,622 shares outstanding at December 31, 2025 and 2024, respectively) | |||||||||
| Treasury shares (13,874,181 and 84,263,150 common shares at December 31, 2025 and 2024, respectively, at cost) | |||||||||
| Additional paid-in capital | |||||||||
| Mandatorily convertible notes | |||||||||
| Retained earnings | |||||||||
| Reserves | |||||||||
| Equity attributable to the equity holders of the parent | |||||||||
| Non-controlling interests | |||||||||
| Total equity | |||||||||
| Total liabilities and equity | |||||||||
| Shares outstanding (in shares) |
Loading...
